Skip to content
FrontierPicks

Dormant

UCTT · Ultra Clean Holdings, Inc.

Last analysed ·

Resolved Graded and closed 2026-08-21 at low conviction — the published kill line fired. Coverage continued after the close; the read below is dated 2026-09-20 and is not part of the scored record.

Current thesis

WFE upcycle intact fundamentally but the tape broke: -35% from the $142.59 all-time close (2026-06-30) back under the ~$95 breakout shelf on sector-wide selling with no company news. Failed breakout, no support to $80.55, binary Q2 print 2026-08-03 AMC. The setup needs a base, not a bounce.

Kill line

A weekly close below $82 breaks the $80.55 June base and turns the July retrace into a trend reversal; secondary condition is Lam or Applied cutting the $140–145B 2026 WFE figure, or a Q3 guide on 2026-08-03 below ~$580M.

Pick status

Invalidated resolved published kill line fired How this is scored →

Latest analysis and events for UCTT —

As of 20 September 2026, the latest FrontierPicks analysis for Ultra Clean Holdings, Inc. (UCTT): WFE upcycle intact fundamentally but the tape broke: -35% from the $142.59 all-time close (2026-06-30) back under the ~$95 breakout shelf on sector-wide selling with no company news. Failed breakout, no support to $80.55, binary Q2 print 2026-08-03 AMC. The setup needs a base, not a bounce.

Kill line: A weekly close below $82 breaks the $80.55 June base and turns the July retrace into a trend reversal; secondary condition is Lam or Applied cutting the $140–145B 2026 WFE figure, or a Q3 guide on 2026-08-03 below ~$580M.

Current Thesis

Ultra Clean Holdings' recovery case depends on record shipments becoming operating cash and the shares reclaiming the previously broken $82 threshold; a subsequent weekly close below the September 18 reference close of $70.64 would invalidate stabilization. Management's August 3, 2026 outlook called for third-quarter revenue of $700–750 million, following second-quarter revenue of $644.9 million. Those are reported guidance and results; successful cash conversion remains an inference to be tested. Second-quarter results.

The original re-rating narrative is dead — the September 6, 2026 dossier had already recorded the breach of its $82 weekly-close threshold, and the September 18 close remains below it. The remaining research question is whether operating delivery can repair that damage. For grading the prospective recovery leg, a weekly close above $82 before a subsequent weekly close below $70.64 constitutes price confirmation; neither outcome has occurred since this reference observation.

Bullish and bearish views on Ultra Clean Holdings, Inc.

The model's bull view on Ultra Clean Holdings, Inc. (UCTT), in brief: Shipment guidance provides a test. The August 3, 2026 results release set third-quarter revenue guidance at $700–750 million. Delivery within that range would confirm the shipment premise; revenue below $700 million would contradict it. Company results. Customer demand had… The bear view: Earnings have not become cash. The August 3, 2026 second-quarter disclosure reported negative operating cash flow of $41.1 million despite positive net income. Another negative quarter would contradict the proposed cash-conversion recovery. Company results. Equity issuance… Both cases follow in full.

Bull Case

  • Shipment guidance provides a test. The August 3, 2026 results release set third-quarter revenue guidance at $700–750 million. Delivery within that range would confirm the shipment premise; revenue below $700 million would contradict it. Company results.
  • Customer demand had external support. Applied Materials reported fiscal third-quarter revenue of $9.115 billion and raised its outlook on August 13, 2026, according to the results cited in the September 6 dossier. This supports the historical equipment-demand backdrop; a subsequent customer outlook reduction would weaken that read-through.
  • Public growth coverage continues. Zacks published a favorable Ultra Clean growth assessment on September 18, 2026. This establishes continuing attention, but the sample is too small to establish expanding participation or a crowded consensus. Zacks assessment.

Bear Case

  • Earnings have not become cash. The August 3, 2026 second-quarter disclosure reported negative operating cash flow of $41.1 million despite positive net income. Another negative quarter would contradict the proposed cash-conversion recovery. Company results.
  • Equity issuance remains an uncertainty. The August 14, 2026 filings established capacity for up to $400 million of common-stock sales, as documented in the September 6 dossier. That authorization is not evidence of completed sales; the amount subsequently issued is not established by the available evidence.
  • Price damage remains substantial. The supplied adjusted series places the September 18, 2026 close at $70.64, down 42.6% over three months and 50.5% below its 52-week high. These measured declines support low conviction in a recovery that still requires a weekly reclaim of $82.

Setup & Price Structure

The September 18, 2026 relative strength index over 14 periods, RSI(14), was 51.6. That reading accompanies substantial price damage; it does not establish a base. No moving-average value, volume series or short-interest observation is available to support a stronger technical or positioning claim.

The prospective failure condition is a subsequent weekly close below $70.64, the September 18 reference close. This is an explicit research boundary, not a claim that the market has established support there. The $82 confirmation threshold refers to the failed condition documented in the September 6 dossier, rather than a newly measured resistance shelf.

Crowding remains unresolved. The September 18 Zacks article establishes favorable retail-facing coverage, while the August 14 financing authorization establishes potential share supply. Neither observation measures actual investor exposure, and the available evidence does not establish insider selling or completed issuance.

Catalyst Calendar (next 30 days)

For September 20 through October 20, 2026, no company-confirmed catalyst date was verified. The accessible company event material does not establish a third-quarter reporting date, so no event inside that window anchors the recovery case. Company event calendar.

  • ~2026-10-27, estimated and unconfirmed: The prospective third-quarter results date remains the estimate published on September 6, 2026, rather than a company announcement. This later event belongs here because the results test the August 3 revenue guidance, operating cash conversion and any disclosed equity issuance.

What Would Change Our Mind

Failure to hold the September 18 reference close would end the proposed stabilization leg: a subsequent weekly close below $70.64 is the price invalidation. The earlier $82 condition has already failed and is not being presented as an untriggered downside boundary.

A weekly close above $82 before that invalidation would establish price repair. Separately, third-quarter revenue within management's August 3 guidance and positive operating cash flow would support the operating recovery; revenue below $700 million or another negative operating-cash-flow quarter would contradict it. No conclusion about realized dilution is justified until a filing supplies the sales information.

Correlation Notes

This remains a single-name recovery case with semiconductor-equipment exposure. The September 6, 2026 dossier identified Lam Research and Applied Materials as major customers, making their order outlooks relevant transmission channels. Applied's August 13 results provide a dated demand observation, not proof that UCTT's financing and cash-conversion questions have been resolved.

The earlier dossier's assertion of near-perfect correlation with Ichor is unsupported by a supplied return series or measurement window. No numerical correlation is established here, and a group rally alone would not satisfy the company-specific operating tests. The historical semiconductor-equipment theme tag describes business exposure rather than confirmed current group participation.

Notes

  • A $400M at-the-market equity program has been live since 2026-08-14; shares are sold at the company's discretion, so the count can rise between periodic filings.
  • Convert-heavy capital structure: $601.9M long-term debt at the Q1 FY26 balance-sheet date; cash and equivalents $255.9M at Q2 FY26.
  • GAAP and non-GAAP results diverge materially: Q2 FY26 GAAP net income $8.7M versus $32.3M non-GAAP.
  • Operating cash flow was negative in both FY26 quarters disclosed to date as inventory built ahead of new capacity.
  • Near-1:1 correlation with ICHR: same OEM customers, same catalyst window, same sector-beta drawdowns.
  • Michael Keogh became CFO effective 2026-08-05, succeeding Sheri Savage; Q3 FY26 will be his first print in the role.

Related · shared themes

See also · stocks to watch